Free Trial
LON:CTEC

ConvaTec Group (CTEC) Share Price, News & Analysis

ConvaTec Group logo
GBX 220.20 +0.40 (+0.18%)
(As of 12/24/2024 08:01 AM ET)

About ConvaTec Group Stock (LON:CTEC)

Key Stats

Today's Range
219.90
222
50-Day Range
213.40
264.40
52-Week Range
211.80
295.20
Volume
3.46 million shs
Average Volume
6.79 million shs
Market Capitalization
£4.51 billion
P/E Ratio
3,670.00
Dividend Yield
2.27%
Price Target
GBX 301.67
Consensus Rating
Buy

Company Overview

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.

Receive CTEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ConvaTec Group and its competitors with MarketBeat's FREE daily newsletter.

CTEC Stock News Headlines

ConvaTec (CTEC) Gets a Buy from UBS
The #1 Coin for November 2024
Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide…
Jefferies Remains a Buy on ConvaTec (CTEC)
ConvaTec’s Strong Performance and Positive Outlook Drive Buy Rating
See More Headlines

CTEC Stock Analysis - Frequently Asked Questions

ConvaTec Group's stock was trading at GBX 244.20 at the start of the year. Since then, CTEC stock has decreased by 9.8% and is now trading at GBX 220.20.
View the best growth stocks for 2024 here
.

ConvaTec Group PLC (LON:CTEC) issued its quarterly earnings data on Friday, February, 28th. The company reported $12.00 EPS for the quarter, missing the consensus estimate of $12.70 by $0.70. ConvaTec Group had a trailing twelve-month return on equity of 9.34% and a net margin of 6.96%.

Shares of CTEC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that ConvaTec Group investors own include EnQuest (ENQ), Centamin (CEY), Lloyds Banking Group (LLOY), Oxford Biomedica (OXB), Tullow Oil (TLW), Barclays (BARC) and Vodafone Group Public (VOD).

Company Calendar

Last Earnings
2/28/2020
Ex-Dividend for 10/4 Dividend
8/22/2024
Dividend Payable
10/04/2024
Today
12/24/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
10,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
GBX 301.67
High Stock Price Target
GBX 310
Low Stock Price Target
GBX 290
Potential Upside/Downside
+37.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
£153.20 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£2.20 billion
Cash Flow
GBX 12.95 per share
Book Value
GBX 81 per share

Miscellaneous

Outstanding Shares
2,050,000,000
Free Float
N/A
Market Cap
£4.51 billion
Optionable
Not Optionable
Beta
0.64
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (LON:CTEC) was last updated on 12/25/2024 by MarketBeat.com Staff
From Our Partners